🇺🇸 FDA
Patent

US 11666606

Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases

granted A61KA61K35/50A61K38/57

Quick answer

US patent 11666606 (Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases) held by Prime Merger Sub, LLC expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Prime Merger Sub, LLC
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/50, A61K38/57, A61K47/36, A61K9/0019